TECHNOLOGICAL NEW ANTINEOPLASTIC APPLICATIONS (Q2031453): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed an Item) |
||
Property / fund | |||
Property / fund: European Regional Development Fund / rank | |||
Normal rank |
Revision as of 17:56, 8 June 2020
Project in Italy financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | TECHNOLOGICAL NEW ANTINEOPLASTIC APPLICATIONS |
Project in Italy financed by DG Regio |
Statements
152,000.0 Euro
0 references
304,000.0 Euro
0 references
50.0 percent
0 references
22 July 2016
0 references
30 April 2019
0 references
DIPARTIMENTO DI SCIENZE CHIMICHE E FARMACEUTICHE
0 references
UNITS PARTECIPERà AL PROGETTO CON I DIPARTIMENTI DI SCIENZE CHIMICHE E FARMACEUTICHE (DSCF) E DI SCIENZE DELLA VITA (DSV), CON COMPETENZE E RUOLI DIFFERENZIATI E COMPLEMENTARI. UNITS-DSCF CURERà LA PROGETTAZIONE, SINTESI E MODIFICA DI NUOVI INIBITORI DI DEUBIQUITINASI (ISOPEPTIDASI) STRUTTURALMENTE COLLEGATI ALL¿INIBITORE 2CPE, LA CUI ATTIVITà ANTINEOPLASTICA Ê STATA RECENTEMENTE DIMOSTRATA IN VITRO E IN VIVO. LA PROGETTAZIONE DI INIBITORI DI SECONDA GENERAZIONE TERRà CONTO DI INFORMA (Italian)
0 references
THE UNITS OF CHEMICAL AND PHARMACEUTICAL SCIENCE (DSCF) AND LIFE SCIENCES (DSV) HAVE DIFFERENTIATED AND COMPLEMENTARY SKILLS AND ROLES. UNITS-DSCF CURRENT THE DESIGN, SYNTHESIS AND MODIFICATION OF NEW DEUBILIQUITINASI (ISISIDASEI) INHIBITORS WHICH ARE STRUCTURALLY RELATED TO THIS 2CPE INHIBITOR, THE ACTIVITY OF WHICH HAS BEEN RECENTLY DEMONSTRATED IN VITRO AND IN VIVO. THE DESIGN OF SECOND GENERATION INHIBITORS WILL INFORM THE (English)
0 references
Identifiers
J96G17000120005
0 references